Christopher David Ozeroff - 22 Nov 2021 Form 4 Insider Report for ARCA biopharma, Inc. (ORKA)

Role
S.V.P., General Counsel
Signature
/s/ Christopher D. Ozeroff
Issuer symbol
ORKA
Transactions as of
22 Nov 2021
Net transactions value
+$113,210
Form type
4
Filing time
23 Nov 2021, 15:53:02 UTC
Next filing
16 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABIO Common Stock Purchase $113,210 +50,000 +5155% $2.26 50,970 22 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $2.21 to $2.329. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased at each separate price.